Article
TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis.
Journal of immunology (Baltimore, Md. : 1950) - 15 Dec 2010
Blohmke Christoph J, Park Julie, Hirschfeld Aaron F, Victor Rachel E, Schneiderman Julia, Stefanowicz Dorota, Chilvers Mark A, Durie Peter R, Corey Mary, Zielenski Julian, Dorfman Ruslan, Sandford Andrew J, Daley Denise, Turvey Stuart E
Abstract excerpt
New treatments are needed to improve the health of people with cystic fibrosis (CF). Reducing lung-damaging inflammation is likely to be beneficial, but specific anti-inflammatory targets have not been identified. By combining cellular immunology with a population-based genetic modifier study, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
